| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Chemical Biology, Osaka City University Medical School (T.H., W.K., T.C., S.I., Y.F.), Osaka 545-8585, Japan; and Department of Drug Metabolism and Pharmacokinetics, Kawanishi Pharma Research Institute, Nippon Boehringer Ingelheim Co. (W.K., T.I.), Hyogo 666-0193, Japan
Address all correspondence and requests for reprints to: Toyoko Hiroi, Ph.D., Department of Chemical Biology, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. E-mail: toyoko-loy{at}med.osaka-cu.ac.jp
The existence of cytochrome P450 2D isoforms in the brain has been
demonstrated, although their physiological functions remain to be
elucidated. In this study we demonstrated that recombinant rat
cytochrome P450 2D1 and 2D4 and human cytochrome P450 2D6 possess
progesterone 6ß- and 16
- hydroxylation activities; 2ß- and
21-hydroxylation activities; and 2ß-, 6ß-, 16
- and
21-hydroxylation activities, respectively. Cytochrome P450 2D4 had the
lowest Km value and the highest maximum velocity value
toward these activities. Progesterone 2ß- and 21-hydroxylation
activities were also detected in rat brain microsomes, and these
activities were completely inhibited by anticytochrome P450 2D
antibodies. The presence of endogenous 2ß- and
21-hydroxyprogesterones in rat brain tissues was also demonstrated. The
mRNAs of cytochrome P450 2D4, CYP11A, and 3ß-hydroxysteroid
dehydrogenase were detected in the rat brain, suggesting that
progesterone was generated from cholesterol by CYP11A and
3ß-hydroxysteroid dehydrogenase and then underwent hydroxylation
to hydroxyprogesterones by cytochrome P450 2D4 in rat brain.
Collectively, our findings support the idea that cytochrome P450 2D may
be involved in the regulation (metabolism and/or synthesis) of
endogenous neuroactive steroids, such as progesterone and its
derivatives, in brain tissues.
This article has been cited by other articles:
![]() |
W. Kishimoto, T. Hiroi, M. Shiraishi, M. Osada, S. Imaoka, S. Kominami, T. Igarashi, and Y. Funae Cytochrome P450 2D Catalyze Steroid 21-Hydroxylation in the Brain Endocrinology, February 1, 2004; 145(2): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Yu, C. P. Granvil, R. L. Haining, K. W. Krausz, J. Corchero, A. Kupfer, J. R. Idle, and F. J. Gonzalez The Relative Contribution of Monoamine Oxidase and Cytochrome P450 Isozymes to the Metabolic Deamination of the Trace Amine Tryptamine J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. I. Paine, L. A. McLaughlin, J. U. Flanagan, C. A. Kemp, M. J. Sutcliffe, G. C. K. Roberts, and C. R. Wolf Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6 J. Biol. Chem., January 31, 2003; 278(6): 4021 - 4027. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Hanna, J. A. Krauser, H. Cai, M.-S. Kim, and F. P. Guengerich Diversity in Mechanisms of Substrate Oxidation by Cytochrome P450 2D6. LACK OF AN ALLOSTERIC ROLE OF NADPH-CYTOCHROME P450 REDUCTASE IN CATALYTIC REGIOSELECTIVITY J. Biol. Chem., October 19, 2001; 276(43): 39553 - 39561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |